Adial Pharmaceuticals, Inc. Investment Owned, at Cost
Adial Pharmaceuticals, Inc. (ADIL) had Investment Owned, at Cost of $2.35 million as of 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Notes › SEC Schedule › Schedule of Investments
us-gaap:InvestmentOwnedAtCost · last filed 2021-05-17
- 2021-03-31: Investment Owned, at Cost $2.35M.
| Period end | Investment Owned, at Cost |
|---|---|
| 2021-03-31 | $2.35M 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |